Cargando…
Consensus Statement on Proton Therapy for Prostate Cancer
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective...
Autores principales: | Bryant, Curtis M., Henderson, Randal H., Nichols, R. Charles, Mendenhall, William M., Hoppe, Bradford S., Vargas, Carlos E., Daniels, Thomas B., Choo, C. Richard, Parikh, Rahul R., Giap, Huan, Slater, Jerry D., Vapiwala, Neha, Barrett, William, Nanda, Akash, Mishra, Mark V., Choi, Seungtaek, Liao, Jay J., Mendenhall, Nancy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489490/ https://www.ncbi.nlm.nih.gov/pubmed/34722807 http://dx.doi.org/10.14338/IJPT-20-00031.1 |
Ejemplares similares
-
Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016) -
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021) -
Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012) -
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013) -
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)